Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Susan S. Kaplan"'
Autor:
Vibhu Kanchan, Khalequ Zaman, Asma Binte Aziz, Sheikh Farzana Zaman, Farzana Zaman, Warda Haque, Mahbuba Khanam, Mohammad Mahbubul Karim, Sachin Kale, Syed Khalid Ali, Michelle G. Goveia, Susan S. Kaplan, Davinder Gill, Wasif Ali Khan, Mohammad Yunus, Ajitpal Singh, John D. Clemens
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 3, Pp 693-702 (2020)
Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18–45 years followed by assessment of safety, reactogenicity, and immunogenicity of three doses of HSRV in health
Externí odkaz:
https://doaj.org/article/05badda615cb4df2864a2b56c7dbf544
Autor:
Zoran Popmihajlov, Lei Pang, Elizabeth Brown, Amita Joshi, Shu-Chih Su, Susan S. Kaplan, English D. Willis
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 2916-2920 (2018)
Background: ZOSTAVAX (ZVL; Zoster Virus Live), is a single dose, live, attenuated vaccine licensed for the prevention of herpes zoster (HZ) and post herpetic neuralgia (PHN) in adults ≥50 years of age. Injection site adverse events (AEs) of erythem
Externí odkaz:
https://doaj.org/article/d2d8d022df1c4b4285f5b3bb7cd593d2
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 10, Pp 2357-2363 (2017)
Although clinical trials of the pentavalent rotavirus vaccine (RotaTeq®, RV5) have demonstrated efficacy against RV gastroenteritis (RGE) in low and high-income settings, a clear correlate of protection or a measure of immune response that could pre
Externí odkaz:
https://doaj.org/article/1471cc6bced24320a70bf638d415e5f7
Autor:
John D. Clemens, Vibhu Kanchan, Sheikh Farzana Zaman, Sachin Kale, Asma Binte Aziz, Davinder Gill, Ajitpal Singh, Farzana Zaman, Wasif A. Khan, Khalequ Zaman, Michelle G. Goveia, Susan S. Kaplan, Mohammad Yunus, Syed Khalid Ali, Mahbuba Khanam, Warda Haque, Mohammad Mahbubul Karim
Publikováno v:
Human Vaccines & Immunotherapeutics
Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18–45 years followed by assessment of safety, reactogenicity, and immunogenicity of three doses of HSRV in health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54cae7231248853431c5472f192caab4
https://doi.org/10.1080/21645515.2019.1664239
https://doi.org/10.1080/21645515.2019.1664239
Autor:
Qiong Shou, Minghuan Zheng, Susan S. Kaplan, Peng Luo, Xueyan Liao, Darcy A. Hille, Zhaojun Mo, Xiao Ma, Beth A. Arnold, Yi Mo
Publikováno v:
Vaccine. 37:1836-1843
Background A phase III, randomized, double-blind, placebo-controlled clinical study was conducted in China to assess the efficacy, safety, and immunogenicity of the pentavalent rotavirus vaccine (RotaTeqTM, RV5) among Chinese infants. The efficacy an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2adfe22181bebb71174901fd5cc9963b
https://doi.org/10.1016/j.vaccine.2019.02.018
https://doi.org/10.1016/j.vaccine.2019.02.018
Autor:
Zoran Popmihajlov, Michael Boeckh, Lei Pang, Drew J. Winston, Kimberly Hurtado, Vicki A. Morrison, Luis H. Camacho, Jessie Durrand Hall, Shu-Chih Su, Kathleen M. Mullane, Ann M. Arvin, Paula W. Annunziato, Susan S. Kaplan
Publikováno v:
Open Forum Infectious Diseases
Background In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZVIN) was well tolerated and efficacious against herpes zoster (HZ) in autologous hematopoietic stem cell transplant (auto-HSCT) recipients and patients with solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f078c0e66a00175181ed00130146a3
http://europepmc.org/articles/PMC7336559
http://europepmc.org/articles/PMC7336559
Autor:
Yi Mo, Yuanzheng Qiu, Jianli Chu, Junhui Tao, Dingkai Wei, Xu Yang, Jilian Kong, Ming-Qiang Li, Susan S. Kaplan, Darcy A. Hille, Zhaojun Mo, Xueyan Liao, Micki Nelson, Botao Fu
Publikováno v:
Vaccine. 35:5897-5904
Background A randomized, double-blind, placebo-controlled multicenter trial was conducted in healthy Chinese infants to assess the efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RotaTeq™, RV5) against rotaviru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eaec95d7cfd108f519687447f588b66
https://doi.org/10.1016/j.vaccine.2017.08.081
https://doi.org/10.1016/j.vaccine.2017.08.081
Publikováno v:
Human Vaccines & Immunotherapeutics. 13:2357-2363
Although clinical trials of the pentavalent rotavirus vaccine (RotaTeq®, RV5) have demonstrated efficacy against RV gastroenteritis (RGE) in low and high-income settings, a clear correlate of protection or a measure of immune response that could pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f597514e2f801dd35f3b758da6111f40
https://doi.org/10.1080/21645515.2017.1356522
https://doi.org/10.1080/21645515.2017.1356522
Autor:
Amanda Zadzilka, Jane C. Lindsey, Kaitlin Rainwater-Lovett, Adriana Weinberg, Mutsa Bwakura-Dangarembizix, Micki Nelson, Deborah Persaud, Priyanka Uprety, Myron J. Levin, Susan S. Kaplan, Carrie Ziemniak
Publikováno v:
The Journal of Infectious Diseases. 215:928-932
Biomarkers of inflammation and immune activation were correlated with rotavirus vaccine responses in 68 human immunodeficiency virus type 1 (HIV-1)–infected (and 116 HIV-exposed but uninfected (HEU) African infants receiving pentavalent rotavirus v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51853985722d0be860ece316559738ec
https://doi.org/10.1093/infdis/jix060
https://doi.org/10.1093/infdis/jix060
Autor:
Myron J. Levin, Jody Lawrence, Adriana Weinberg, Mutsa Bwakura-Dangarembizi, Anthony Ogwu, Evans M. Mpabalwani, George K. Siberry, Werner Schimana, Margaret Nelson, Susan S. Kaplan, Jane C. Lindsey, Paul A. Sato, Darcy A. Hille, Geoffrey A. Weinberg, Monica M. McNeal
Publikováno v:
AIDS. 31:49-59
OBJECTIVE Although many HIV-infected (HIV+) and HIV-exposed but uninfected (HEU) infants have received live rotavirus vaccines since the WHO recommended universal administration of these vaccines to infants, there has been limited prospective informa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c973c45cde03da71cdae54d76d821214
https://doi.org/10.1097/qad.0000000000001258
https://doi.org/10.1097/qad.0000000000001258